Effects of Soft Tissue Mobilization Technique and Piriformis Muscle Stretching Among Patients Having Piriformis Syndrome

NCT ID: NCT05680402

Last Updated: 2023-01-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-02

Study Completion Date

2022-12-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It is a randomized control trail in which soft tissue mobilization and piriformis stretching will be compared and study duration will be of five months

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Piriformis syndrome is one of the misdiagnosed syndromes and there is no evidence available for the proper diagnosis of this syndrome. Several interventions have been adopted in the clinical setting for improvement of piriformis syndrome including therapeutic ultrasound, myofascial release, stretching, dry needling, strengthening exercises of hip muscles and activity modification. There are several treatments available for this syndrome but no comparison studies have been reported yet on soft tissue mobilization and piriformis muscle stretching. The purpose for conducting this research is to assist in establishing the effectiveness of soft tissue mobilization technique and piriformis muscle stretching in piriformis syndrome by comparison between two abovementioned treatments

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Piriformis Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized Control Clinical Trial in which group 1 will be of experimental group and group 2 will be of control group
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants
Single Blind RCT in which only participants will not know about the type of treatment undergoing

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

Soft tissue mobilization

Group Type EXPERIMENTAL

Soft Tissue mobilization

Intervention Type OTHER

mobilization of soft tissues of body

Group 2

Piriformis Stretching

Group Type ACTIVE_COMPARATOR

Piriformis Syndrome (Piriformis muscle stretching)

Intervention Type OTHER

Stretching of Piriformis muscle

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Soft Tissue mobilization

mobilization of soft tissues of body

Intervention Type OTHER

Piriformis Syndrome (Piriformis muscle stretching)

Stretching of Piriformis muscle

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males and females with age between 25 and 45 years
* Patients with positive piriformis test
* Pain at least 3 according to numeric pain rating scale (NPRS)

Exclusion Criteria

* History of hip pain due to any diagnosed hip pathology
* Leg length discrepancy
* Past history of spinal surgery
* Spinal tuberculosis
* Rheumatoid disease,
Minimum Eligible Age

25 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Physiotherapy Clinic Iqra University Islamabad (Chak Shahzad)

UNKNOWN

Sponsor Role collaborator

Noor Hospital Tarnol, Islamabad

UNKNOWN

Sponsor Role collaborator

Neuro Counsel Hospital, Pakistan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Muhammad Kamran, M.Phil*

Role: PRINCIPAL_INVESTIGATOR

Al Nafees medical College Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Physiotherapy Clinic Iqra University Islamabad (Chak Shahzad)

Islamabad, Federal, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

339

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.